|
|
|
|
|
Neuro-Oncology
Reviews
|
|
|
|
Volume
24 Number 12
30 June 2022
|
|
|
|
Home
>
Publications
>
Neuro-Oncology
Reviews >
Volume
24, Year 2022 >
Number 12, 30 June
|
|
|
|
|
*
|
Osborn
AG, Louis DN, Poussaint TY, Linscott LL, Salzman KL.
The
2021 World Health Organization Classification of Tumors of the
Central Nervous System: What Neuroradiologists Need to Know.
AJNR
Am J Neuroradiol. 2022 Jun 16→.
doi: 10.3174/ajnr.A7462→.
PMID: 35710121→.
Review.
ˍ
|
|
|
*
|
Prajapati
HP, Kannaujia SK.
A
simplified overview of the World Health Organization
classification of central nervous system tumors 2021.
Surg
Neurol Int. 2022 Jun 17;13:252→.
doi: 10.25259/SNI_102_2022→.
PMID: 35855126→.
Review. ˍ
|
|
|
|
McMahon
DJ, Gleeson JP, O'Reilly S, Bambury RM.
Management
of newly diagnosed glioblastoma multiforme: current state of the
art and emerging therapeutic approaches.
Med
Oncol. 2022 Jun 18;39(9):129→.
doi: 10.1007/s12032-022-01708-w→.
PMID: 35716200→.
Review˰ ˍ
|
|
|
|
Horbinski
C, Berger T, Packer RJ, Wen PY.
Clinical
implications of the 2021 edition of the WHO classification of
central nervous system tumours.
Nat
Rev Neurol. 2022 Jun 21→.
doi: 10.1038/s41582-022-00679-w→.
PMID: 35729337→.
Review˰ ˍ
|
|
|
|
Balana
C.
Optimal
duration of adjuvant temozolomide in glioblastoma: An unsolved and
unsolvable problem.
Neurooncol
Pract. 2022 Jun 22;9(5):349-350→.
doi: 10.1093/nop/npac054→.
PMID: 36134019→.
Comment˰ ˍ
Refers
to: Gupta
T, et al., Efficacy
and safety of extended adjuvant temozolomide compared to standard
adjuvant temozolomide in glioblastoma: Updated systematic review
and meta-analysis.
Neurooncol
Pract. 2022 May 7;9(5):354-363→.
doi: 10.1093/nop/npac036→.
PMID: 36134016→.
Review, Meta-analysis. ˍ
|
|
|
|
Rallis
KS, George AM, Wozniak AM, Bigogno CM, Chow B, Hanrahan JG,
Sideris M.
Molecular
Genetics and Targeted Therapies for Paediatric High-grade
Glioma.
Cancer
Genomics Proteomics. 2022 Jun 22;19(4):390-414→.
doi: 10.21873/cgp.20328→.
PMID: 35732328→.
Review. ˍ
|
|
|
|
Ricciardi
L, Manini I, Cesselli D, Trungu S, Piazza A, Mangraviti A, Miscusi
M, Raco A, Ius T.
Carmustine
Wafers Implantation in Patients With Newly Diagnosed High Grade
Glioma: Is It Still an Option?
Front
Neurol. 2022 Jun 23;13:884158→.
doi: 10.3389/fneur.2022.884158→.
PMID: 35812101→.
Review, Meta-analysis. ˍ
|
|
|
|
Du
X, He Y, Lin W.
Diagnostic
Accuracy of the Diffusion-Weighted Imaging Method Used in
Association With the Apparent Diffusion Coefficient for
Differentiating Between Primary Central Nervous System Lymphoma
and High-Grade Glioma: Systematic Review and Meta-Analysis.
Front
Neurol. 2022 Jun 24;13:882334→.
doi: 10.3389/fneur.2022.882334→.
PMID: 35812103→.
Review, Meta-analysis. ˍ
|
|
|
|
Evans
M, Gill R, Bull KS.
Does
a Bevacizumab-based regime have a role in the treatment of
children with diffuse intrinsic pontine glioma? A systematic
review.
Neurooncol
Adv. 2022 Jun 24;4(1):vdac100→.
doi: 10.1093/noajnl/vdac100→.
PMID: 35821674→.
Review. ˍ
|
|
|
|
Sener
U, Ruff MW, Campian JL.
Immunotherapy
in Glioblastoma: Current Approaches and Future Perspectives.
Int
J Mol Sci. 2022 Jun 24;23(13):7046→.
doi: 10.3390/ijms23137046→.
PMID: 35806051→.
Review.
ˍ
|
|
|
|
El-Abtah
ME, Talati P, Dietrich J, Gerstner ER, Ratai EM.
Magnetic
resonance spectroscopic imaging for detecting metabolic changes in
glioblastoma after anti-angiogenic therapy-a systematic literature
review.
Neurooncol
Adv. 2022 Jun 27;4(1):vdac103→.
doi: 10.1093/noajnl/vdac103→.
PMID: 35892047→.
Review. ˍ
|
|
|
|
Pirozzi
M, Caterino M, Facchini S, Zotta A, Messina G, Rauso R, Sica A,
Sciano D, Facchini G, Orditura M, Somma T, Maiuri F, Cappabianca
P, Ciardiello F, Fasano M.
Regorafenib
beyond the Second Line in Relapsed Glioblastoma: A Case Report and
Literature Review.
Case
Rep Oncol. 2022 Jun 27;15(2):642-647→.
doi: 10.1159/000524954→.
PMID: 35949909→.
Case
report, Review. ˍ
|
|
|
|
Di
Nunno V, Fordellone M, Minniti G, Asioli S, Conti A, Mazzatenta D,
Balestrini D, Chiodini P, Agati R, Tonon C, Tosoni A, Gatto L,
Bartolini S, Lodi R, Franceschi E.
Machine
learning in neuro-oncology: toward novel development fields.
J
Neurooncol. 2022 Jun 28→.
doi: 10.1007/s11060-022-04068-7→.
PMID: 35761160→.
Review˰ ˍ
|
|
|
|
Li AY, Iv M.
Conventional and Advanced
Imaging Techniques in Post-treatment Glioma Imaging.
Front
Radiol. 2022 Jun 28;2:883293∟.
doi: 10.3389/fradi.2022.883293∟.
PMID: 37492665∟.
Review. ˍ
|
|
|
|
Galijasevic
M, Steiger R, Mangesius S, Mangesius J, Kerschbaumer J, Freyschlag
CF, Gruber N, Janjic T, Gizewski ER, Grams AE.
Magnetic
Resonance Spectroscopy in Diagnosis and Follow-Up of Gliomas:
State-of-the-Art.
Cancers
(Basel). 2022 Jun 29;14(13):3197→.
doi: 10.3390/cancers14133197→.
PMID: 35804969→.
Review.
ˍ
|
|
|
|
Rodríguez-Camacho
A, Flores-Vázquez JG, Moscardini-Martelli J, Torres-Ríos
JA, Olmos-Guzmán A, Ortiz-Arce CS, Cid-Sánchez DR,
Pérez SR, Macías-González MDS,
Hernández-Sánchez LC, Heredia-Gutiérrez JC,
Contreras-Palafox GA, Suárez-Campos JJE, Celis-López
MÁ, Gutiérrez-Aceves GA, Moreno-Jiménez
S.
Glioblastoma
Treatment: State-of-the-Art and Future Perspectives.
Int
J Mol Sci. 2022 Jun 29;23(13):7207→.
doi: 10.3390/ijms23137207→.
PMID: 35806212→.
Review. ˍ
|
|
|
|
Vuong
HG, Dunn IF.
Primary
versus secondary gliosarcoma: a systematic review and
meta-analysis.
J
Neurooncol. 2022 Jun 29→.
doi: 10.1007/s11060-022-04057-w→.
PMID: 35768633→.
Review, Meta-analysis˰ ˍ
|
|
|
|
Al
Sharie S, Talafha M, Abu Laban D, Al Awabdeh T, Al-Mousa A,
Al-Masri N, Al-Hussaini M.
H3
K27M-mutant diffuse midline glioma with osseous metastases: A case
report and a literature review.
Clin
Neuropathol. 2022 Jun 30→.
doi: 10.5414/NP301475→.
PMID: 35770519→.
Case report, Review˰ ˍ
|
|
|
|
Cruz
JVR, Batista C, Afonso BH, Alexandre-Moreira MS, Dubois LG, Pontes
B, Moura Neto V, Mendes FA.
Obstacles
to Glioblastoma Treatment Two Decades after Temozolomide.
Cancers
(Basel). 2022 Jun 30;14(13):3203→.
doi: 10.3390/cancers14133203→.
PMID: 35804976→.
Review. ˍ
|
|
|
|
Giustozzi
M, Proietti G, Becattini C, Roila F, Agnelli G, Mandalà
M.
ICH
in patients with primary or metastatic brain cancer treated or not
with anticoagulants: a systematic review and meta-analysis.
Blood
Adv. 2022 Jun 30:bloodadvances.2022008086→.
doi: 10.1182/bloodadvances.2022008086→.
PMID: 35772127→.
Review, Meta-analysis. ˍ
|
|
|
|
Prajapati
HP, Ansari A.
Updates
in the Management of Recurrent Glioblastoma Multiforme.
J
Neurol Surg A Cent Eur Neurosurg. 2022 Jun 30→.
doi: 10.1055/s-0042-1749351→.
PMID: 35772723→.
Review˰ ˍ
|
|
|
*
|
Sejda
A, Grajkowska W, Trubicka J, Szutowicz E, Wojdacz T, Kloc W,
Iżycka-Świeszewska E.
WHO
CNS5 2021 classification of gliomas: a practical review and road
signs for diagnosing pathologists and proper patho-clinical and
neuro-oncological cooperation.
Folia
Neuropathol. 2022 Jun 30;60(2):137-152→.
doi: 10.5114/fn.2022.118183→.
PMID: 35950467→.
Review. ˍ
|
|
|
|
Smith
KA, Hendricks BK, DiDomenico JD, Conway BN, Smith TL, Azadi A,
Fonkem E.
Ketogenic
Metabolic Therapy for Glioma.
Cureus.
2022 Jun 30;14(6):e26457→.
doi: 10.7759/cureus.26457→.
PMID: 35923675→.
Review. ˍ
|
|
|
|
|
|
|
|
|
|
|